FIELD: medicine.
SUBSTANCE: there is claimed application of dipeptidyl peptidase IV inhibitor (DPP-IV inhibitor), vildagliptin or its salt for production of medication for prevention, retardation of progress or treatment of peripheral diseases such as peripheral neuropatia, neurodegenerative disorders, cognitive disorders, as well as for improvement of memory and ability to learn, and pharmaceutical composition for the same purpose. It is demonstrated: vildagliptin increases stage of wakefulness and response to external stimuli, increases REM sleep phase.
EFFECT: combination of vildagliptin with donepezil considerably improves disturbed ability to learn.
23 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
LIGAND WITH WIDE RANGE OF SIMULTANEOUS RECEPTOR ACTIVITY, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING SAID COMPOSITION AND MEDICINAL AGENT | 2008 |
|
RU2374245C1 |
BENZO[d] ISOXAZOLE-3 DAAO INHIBITORS | 2004 |
|
RU2384574C2 |
SUBSTITUTED 3-ARYLSULFONYL-PYRAZOLO[1,5-a]PYRIMIDINE-2,6-DIAMINES, SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2010 |
|
RU2421456C1 |
APPLICATION OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 2004 |
|
RU2385723C2 |
(3-ARYLSULPHONYL QUINOLIN-8-YL-DIALKYL-AMINES - SELECTIVE SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF | 2012 |
|
RU2500672C1 |
SUBSTITUTED CYCLOALKANO[e OR d]PYRAZOLO[1,5-a]PYRIMIDINE-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHOD OF PRODUCING SAID COMPOUNDS AND USE | 2008 |
|
RU2374249C1 |
TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES - SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2391343C1 |
FOOD COMPOSITION FOR PATIENTS SUFFERING FROM PRODROMAL DEMENTIA | 2008 |
|
RU2487557C2 |
2-ALKYLAMINO-3-ARYLSULPHONYLCYCLOALKANO [e OR d]PYRAZOLO[1,5-a] PYRIMIDINES SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS FOR MAKING AND APPLYING THEREOF | 2008 |
|
RU2377244C1 |
SELECTIVE BUTYRYLCHOLIN ESTERASE INHIBITORS | 2005 |
|
RU2386627C2 |
Authors
Dates
2010-07-20—Published
2005-02-18—Filed